发明申请
WO1992018118A1 MEDICAMENTS 审中-公开
药物

MEDICAMENTS
摘要:
Pharmaceutical compositions are described comprising methylthioribose (MTR) kinase inhibitors (e.g. trifluoromethylthioribose) and inhibitors of de novo methionine synthesis (e.g. 1,2,4-triazole, azaserine or propargylglycine).
0/0